Obesity costs the UK £100 billion a year, yet stigma still clouds the conversation. Science shows it’s more than willpower—genetics which drive up to 80% of weight gain, and new treatments are changing the game. With weight loss medications proving effective and the government backing their use, is it time to rethink our approach? More than one in ten women in the UK already use GLP-1s for weight management, but 31% hesitate due to stigma — highlighting the urgent need to shift public perception. Joining Adam Cox today is pharmacist Kevin Joshua from Juniper Technologies UK Ltd, who will discuss the future of obesity treatment and its impact on public health.
